Today: 21 March 2026
Subscribe
Browse Category

NYSE:WFC 14 January 2026 - 22 January 2026

Wells Fargo stock pops as banks rally on tariff relief, with Fed meeting ahead

Wells Fargo stock pops as banks rally on tariff relief, with Fed meeting ahead

Wells Fargo shares rose 2.6% to $88.38 Thursday as U.S. banks rallied after President Trump eased tariff threats on Europe. The bank will move its wealth-management headquarters to West Palm Beach, relocating about 100 staff by year-end. Wells Fargo also issued $2.76 million in callable notes due 2036 at 4.85%. Investors await the Federal Reserve’s late-January rate decision.
22 January 2026
·····
JPMorgan Chase stock rises as Trump’s 10% credit-card cap plan keeps banks on edge

JPMorgan Chase stock rises as Trump’s 10% credit-card cap plan keeps banks on edge

JPMorgan shares rose 1.2% to $305.57 Thursday as major U.S. banks rallied. CEO Jamie Dimon called a proposed cap on credit-card rates an “economic disaster” at Davos, while Donald Trump urged Congress to impose a 10% cap for one year. New inflation and spending data fueled rate speculation ahead of next week’s Fed meeting. The Dow gained about 0.5% in early trading.
22 January 2026
····
Morgan Stanley stock price rebounds as tariff scare eases; rate-cap risk still hangs over banks

Morgan Stanley stock price rebounds as tariff scare eases; rate-cap risk still hangs over banks

Morgan Stanley shares rose 0.6% to $183.32 in after-hours trading Wednesday, rebounding from a 3.7% drop Tuesday tied to concerns over a proposed 10% cap on credit card interest rates. The move followed Wall Street gains after President Trump announced a framework deal on Greenland and scrapped planned tariffs. Morgan Stanley also issued €5 billion in senior notes in European debt markets. Peers showed mixed after-hours moves.
22 January 2026
······
Wells Fargo stock price slips as credit-card rate cap fight hits banks — what’s next

Wells Fargo stock price slips as credit-card rate cap fight hits banks — what’s next

Wells Fargo shares fell 1.9% to $86.66 Tuesday as bank stocks dropped on concerns over a proposed 10% cap on credit-card interest rates. President Trump is pushing the limit, but details on implementation remain unclear. The American Bankers Association warns up to 159 million cardholders could lose access if the cap is enacted. Wells Fargo will appear at a key conference Feb. 10.
21 January 2026
·
JPMorgan share price slides after hours as Trump credit-card rate cap deadline rattles banks

JPMorgan share price slides after hours as Trump credit-card rate cap deadline rattles banks

JPMorgan shares fell 3.1% to $302.74 in after-hours trading Tuesday, following a drop during the regular session. Investors reacted to uncertainty over a proposed 10% cap on credit-card interest rates tied to a Jan. 20 deadline from the Trump administration. The S&P 500 Banks index lost 2.3% as broader markets also declined on renewed tariff threats. Bank executives warned the cap could restrict credit access for millions.
21 January 2026
····
Wells Fargo stock slips as credit-card rate cap deadline hits — what could move WFC next

Wells Fargo stock slips as credit-card rate cap deadline hits — what could move WFC next

Wells Fargo shares fell 0.6% to $87.84 midday Tuesday as U.S. bank stocks slid ahead of a Trump administration deadline on a proposed 10% credit card rate cap. The S&P 500 Banks index dropped 1.2%. Bank executives and lobbyists warned the cap could force mass account closures and limit credit. Investors await further guidance and the Federal Reserve meeting next week.
20 January 2026
·
Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo shares closed at $88.38 Friday, down 0.65%, as investors await details on President Trump’s proposal to cap credit card interest rates at 10% starting Jan. 20. U.S. equity futures fell over 1.2% after new tariff threats targeting eight European countries. Wall Street will remain closed Monday for Martin Luther King Jr. Day. Banks say they still lack clarity on how the proposed rate cap would be enforced.
19 January 2026
··
KLA stock price holds near fresh highs after TSMC capex jolt; analysts lift targets ahead of earnings

KLA stock price holds near fresh highs after TSMC capex jolt; analysts lift targets ahead of earnings

KLA Corp shares closed at $1,567.82 Friday, up 1.48% after a 7.70% jump Thursday, as chip-equipment stocks rallied on TSMC’s record profit and $52–56 billion capex plan. Morgan Stanley and Wells Fargo raised KLA’s rating and price targets sharply. The Philadelphia semiconductor index rose 1.2%. KLA reports fiscal Q2 results Jan. 29 after market close.
17 January 2026
······
JPMorgan lawsuit threat and credit-card cap: what to watch in U.S. financial stocks next week

JPMorgan lawsuit threat and credit-card cap: what to watch in U.S. financial stocks next week

Donald Trump said he plans to sue JPMorgan Chase, accusing the bank of “debanking” him. Financial stocks were mixed Friday, with the S&P 500 financial sector up 0.1% but posting its worst week since October. PNC Financial jumped 3.7% on strong earnings, while Regions Financial fell 2.6% after a weak outlook. U.S. markets will be closed Monday for the Martin Luther King Jr. holiday.
17 January 2026
······
Wells Fargo stock slips after hours as earnings miss, 2026 outlook and credit-card cap talk weigh on WFC

Wells Fargo stock slips after hours as earnings miss, 2026 outlook and credit-card cap talk weigh on WFC

Wells Fargo shares slipped 0.3% to $88.96 in after-hours trading Thursday, following a 4.6% drop after the bank missed profit estimates and cut its 2026 net interest income outlook. The bank reported $5.4 billion in fourth-quarter net income and repurchased $5 billion in stock. Investors are watching Washington’s proposed credit-card rate cap and upcoming bank earnings.
16 January 2026
·
Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research stock rises after hours as TSMC capex signal and analyst upgrades lift chip tools

Lam Research shares jumped 4.2% to $217.47 in after-hours trading Thursday, following broker upgrades and TSMC’s announcement of higher 2026 spending plans. Applied Materials, KLA, and U.S.-listed TSMC shares also posted strong gains. Wells Fargo, RBC Capital, Stifel, Morgan Stanley, and Barclays all raised price targets for Lam, citing robust demand in wafer-fab equipment and AI-related growth.
15 January 2026
·······
Wells Fargo stock today: WFC wobbles after earnings miss, interest-income outlook back in the spotlight

Wells Fargo stock today: WFC wobbles after earnings miss, interest-income outlook back in the spotlight

Wells Fargo shares slipped 0.3% to $89.00 Thursday morning after a 4.6% drop Wednesday, triggered by weaker-than-expected Q4 profit and net interest income. The bank took a $612 million severance charge and projected 2026 interest income below analyst estimates. Wells Fargo repurchased $5 billion in shares in Q4 and outlined new profitability targets. Investors remain focused on credit card rate policy risks.
15 January 2026
··
US stock futures today: TSMC lifts chip stocks as traders scan the U.S. economic calendar

US stock futures today: TSMC lifts chip stocks as traders scan the U.S. economic calendar

U.S. stock index futures rose early Thursday, led by a 0.74% jump in Nasdaq 100 contracts after TSMC’s record earnings and strong chip outlook. S&P 500 futures gained 0.32%, Dow futures edged up 0.06%. Goldman Sachs and Morgan Stanley will report earnings before the open. Weekly jobless claims and key regional factory surveys are due later this morning.
15 January 2026
········
Dow Jones futures edge higher after TSMC forecast, with banks back in focus

Dow Jones futures edge higher after TSMC forecast, with banks back in focus

Dow Jones futures rose 0.06% early Thursday after TSMC projected strong growth and signaled plans to expand U.S. manufacturing. The Dow closed down 0.09% Wednesday, pressured by falling bank shares amid concerns over a proposed cap on credit-card rates. Wells Fargo dropped 4.6% after missing profit targets. Oil prices slid more than 2% in early Asian trading.
15 January 2026
········
Stock market today: Nasdaq slides as bank earnings and credit-card cap talk hit Wall Street

Stock market today: Nasdaq slides as bank earnings and credit-card cap talk hit Wall Street

Nasdaq fell 1% Wednesday as tech and bank shares slid; S&P 500 lost 0.53% and the Dow slipped 0.09%. Wells Fargo dropped 4.6% after missing profit targets and reporting $612 million in severance charges. Visa and Mastercard tumbled after President Trump proposed a 10% cap on credit-card interest rates. The Russell 2000 closed at a record high.
15 January 2026
·······
Wells Fargo stock drops after earnings miss as rate-cap fears linger — what to watch next

Wells Fargo stock drops after earnings miss as rate-cap fears linger — what to watch next

Wells Fargo shares fell 4.6% to $89.25 in after-hours trading after quarterly earnings and a 2026 net interest income forecast missed expectations. Executives cited uncertainty over a proposed federal cap on credit card rates. The bank posted $21.29 billion in revenue and $5.36 billion in net income for the quarter. Wells Fargo set aside $612 million for severance, signaling more layoffs ahead.
14 January 2026
··
1 2 3 4 5 … 7

Stock Market Today

  • Grail Shares Surge 12.4% After Analyst Upgrade Amid Trial Uncertainty
    March 21, 2026, 6:53 AM EDT. Shares of multi-cancer early detection company Grail jumped up to 12.4% this week following a Wall Street analyst's rating upgrade from "hold" to "buy." The new price target, however, was lowered to $65, still offering a 39% premium over the last close. This comes despite the company missing its primary endpoint in a key trial measuring stage III-IV cancer detection reductions with its Galleri test. The trial did show promising increases in early-stage cancer detection and reduced late-stage cases, which investors hope will be bolstered by upcoming follow-up data. Analyst TD Cowen cited potential for FDA approval and insurance coverage as reasons for optimism in a volatile healthcare stock environment.
Go toTop